Table 2 Descriptive statistics for IOP by visit and time point

From: Ocular hypotensive effect of fixed-combination brinzolamide/brimonidine adjunctive to a prostaglandin analog: a randomized clinical trial

 

BBFC+PGA

Vehicle+PGA

 

Mean±SE IOP, mm Hg

Mean±SE IOP, mm Hg

 

n

IOP

IOP change from baseline

Percent IOP change from baseline

n

IOP

IOP change from baseline

Percent IOP change from baseline

Baseline

 0800 hours

88

24.5±0.3

94

24.3±0.3

 1000 hours

88

22.9±0.2

94

22.6±0.3

 1500 hours

88

21.7±0.3

94

21.3±0.3

 1700 hours

88

21.6±0.3

94

21.2±0.4

 Mean diurnal

88

22.7±0.2

94

22.4±0.3

Week 2

 0800 hours

88

18.8±0.4

−5.6±0.4

−22.8±1.6

94

21.8±0.4

−2.5±0.3

−10.3±1.3

 1000 hours

86

15.7±0.4

−7.2±0.4

−31.5±1.6

93

20.2±0.4

−2.4±0.3

−10.5±1.3

 1500 hours

86

16.9±0.3

−4.8±0.3

−21.8±1.4

93

19.9±0.4

−1.5±0.4

−6.1±1.6

 1700 hours

86

15.3±0.4

−6.3±0.4

−28.8±1.5

92

19.4±0.4

−1.8±0.3

−7.5±1.7

 Mean diurnal

88

16.8±0.3

−6.0±0.3

−26.0±1.3

94

20.4±0.4

−2.0±0.3

−8.5±1.2

Week 6

 0800 hours

83

19.4±0.4

−5.1±0.4

−20.6±1.5

92

21.4±0.5

−2.9±0.4

−12.0±1.4

 1000 hours

83

15.8±0.4

−7.1±0.4

−30.9±1.7

92

20.2±0.4

−2.4±0.3

−10.6±1.5

 1500 hours

83

17.2±0.3

−4.5±0.3

−20.6±1.4

92

19.9±0.4

−1.4±0.4

−6.1±1.6

 1700 hours

83

15.6±0.3

−5.9±0.3

−27.4±1.4

92

19.9±0.5

−1.2±0.4

−5.3±1.6

 Mean diurnal

83

17.0±0.3

−5.7±0.3

−24.9±1.2

92

20.4±0.4

−2.0±0.3

−8.5±1.3

  1. Abbreviations: BBFC, fixed-combination brinzolamide 1%/brimonidine 0.2%; IOP, intraocular pressure; PGA, prostaglandin analog; SE, standard error.